Skip to main content
SPHS logo

Sophiris Bio, Inc. (SPHS) Stock Analysis

DELISTED

What happened to Sophiris Bio, Inc. (SPHS) stock?

Sophiris Bio, Inc. (SPHS) no longer trades on public markets. The figures below are historical and are not a current quote.

Status:
Delisted — no longer trades
Vol: 1.0K| 52-wk range: $0.000001 – $0.000001
Data from FMP · Methodology

For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Sophiris Bio, Inc. (SPHS). Sophiris Bio Corp., now known as Palisade Bio, Inc., is a biopharmaceutical company focused on developing novel therapeutics for acute and chronic gastrointestinal (GI) complications.

Last analyzed: Mar 17, 2026
Sophiris Bio Corp., now known as Palisade Bio, Inc., is a biopharmaceutical company focused on developing novel therapeutics for acute and chronic gastrointestinal (GI) complications. The company's lead asset, PALI-210, is being developed to accelerate the return of bowel function following surgery and reduce abdominal adhesions.

Sophiris Bio, Inc. (SPHS) Healthcare & Pipeline Overview

Employees6
Model self-rating on this text: 54% (not a measure of the evidence) Updated: Mar 17, 2026

SPHS OTC Market Information

SPHS trades on the OTC Other market tier of OTC Markets.

  • OTC Tier: OTC Other

More about this archive record

Can I still buy SPHS shares?

No. SPHS stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for SPHS elsewhere is historical data, not a live market.

Are the figures on this page current?

No. Every number here is the last value recorded before SPHS stopped trading. Nothing on this page updates, and none of it is a current quote.

Why does this page still exist?

Because people still search for what happened to Sophiris Bio, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. Last updated: .

Data provided for informational purposes only.